“Drug-tolerant cells” emerge for the first time from the research of Sharma et al., who modelled the acute response to various anti-cancer agents in drug-sensitive human tumor cell lines, including EGFR mutant NSCLC-derived cell line PC9 [11]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.